ABRYSVO: payments to doctors
Payments that named ABRYSVO as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $4.3M
- Providers
- 56,088
- Transactions
- 135,447
- Average per transaction
- $32
The per-transaction average — $32 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 56,088 providers the average total is $77, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Pfizer | $4,323,080 | 99.8% |
| PBG Puerto RICO LLC | $6,420 | 0.1% |
| Pfizer Chile S.A. | $2,000 | 0.0% |
| Array Biopharma Inc | $47 | 0.0% |